Search alternatives:
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
significant a » significant _ (Expand Search), significant i (Expand Search), significant gap (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 161 - 180 results of 76,047 for search '(( significantly higher decrease ) OR ( significant a decrease ))', query time: 1.25s Refine Results
  1. 161
    Proportion of VD<sub>3</sub> sufficient vs. deficient mice surviving from BCR-ABL ALL when treated with dexamethasone.

    Proportion of VD<sub>3</sub> sufficient vs. deficient mice surviving from BCR-ABL ALL when treated with dexamethasone. by Kavya Annu (11587215)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  2. 162
    Gene expression (qPCR) data from duodenums of C57BL/6 mice before and after DEX treatment.

    Gene expression (qPCR) data from duodenums of C57BL/6 mice before and after DEX treatment. by Kavya Annu (11587215)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  3. 163
    DEX oral gavage PK raw data.

    DEX oral gavage PK raw data. by Kavya Annu (11587215)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  4. 164
    Cartoon depicting hypothesis that dexamethasone-activated PXR can induce Cyp3a in VD<sub>3</sub> deficient mice, but not in VD<sub>3</sub> sufficient mice where 1,25(OH)<sub>2</sub>D<sub>3</sub> activated VDR blocks DEX-PXR induction.

    Cartoon depicting hypothesis that dexamethasone-activated PXR can induce Cyp3a in VD<sub>3</sub> deficient mice, but not in VD<sub>3</sub> sufficient mice where 1,25(OH)<sub>2</sub... by Kavya Annu (11587215)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  5. 165
    Dasatinib plasma pharmacokinetics in male and female VD<sub>3</sub> sufficient and deficient mice after a single oral gavage of 10 mg/kg dasatinib.

    Dasatinib plasma pharmacokinetics in male and female VD<sub>3</sub> sufficient and deficient mice after a single oral gavage of 10 mg/kg dasatinib. by Kavya Annu (11587215)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  6. 166
    Gene expression (qPCR) data from VD3 sufficient and deficient hCYP3A4 12-week-old mice duodenum.

    Gene expression (qPCR) data from VD3 sufficient and deficient hCYP3A4 12-week-old mice duodenum. by Kavya Annu (11587215)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  7. 167
    Dasatinib oral gavage PK raw data.

    Dasatinib oral gavage PK raw data. by Kavya Annu (11587215)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  8. 168
    Significant decrease of the viability of A375 melanoma cells after CD treatment.

    Significant decrease of the viability of A375 melanoma cells after CD treatment. by Lena Berning (7430117)

    Published 2019
    Save to List
    Saved in:
  9. 169
    Exposure to biologics during pregnancy does not affect placental antibody transfer of anti-SARS-CoV-2 neutralizing antibodies, but concomitant corticosteroid exposure may decrease antibody transfer.

    Exposure to biologics during pregnancy does not affect placental antibody transfer of anti-SARS-CoV-2 neutralizing antibodies, but concomitant corticosteroid exposure may decrease... by Donna E. Leet (22772478)

    Published 2025
    Save to List
    Saved in:
  10. 170
    A map indicating study areas and locations of samples.

    A map indicating study areas and locations of samples. by Matti Viluksela (321291)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 171
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 172
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 173
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 174
    Comparison of Alzheimer’s disease pathology in the hippocampus between the CCH and control groups.

    Comparison of Alzheimer’s disease pathology in the hippocampus between the CCH and control groups. by Jung-In Lee (1731727)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 175
    Cerebral glucose metabolism measured by F-18 FDG PET.

    Cerebral glucose metabolism measured by F-18 FDG PET. by Jung-In Lee (1731727)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 176
    Comparison of cerebral infarct volume between the CCH and control groups.

    Comparison of cerebral infarct volume between the CCH and control groups. by Jung-In Lee (1731727)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 177
    Comparison of spatial working memory assessed by the Y-maze test between the CCH and control groups.

    Comparison of spatial working memory assessed by the Y-maze test between the CCH and control groups. by Jung-In Lee (1731727)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 178
    Comparison of CBF between the CCH and control groups.

    Comparison of CBF between the CCH and control groups. by Jung-In Lee (1731727)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 179
    Flow diagram of the study.

    Flow diagram of the study. by Yoonjee Cho (15453454)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  20. 180
    Baseline characteristics of patients.

    Baseline characteristics of patients. by Yoonjee Cho (15453454)

    Published 2023
    Subjects:
    Save to List
    Saved in:

Search Tools: